V Wealth Advisors’s United Therapeutics UTHR Stock Holding History

V Wealth Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,215	Closed	-$268K	–	339
2020 Q2	$268K	Buy	+2,215	New	+$249K	0.07%	288

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

V Wealth Advisors's UTHR Position: Q3 2020 in Review

V Wealth Advisors sold out of United Therapeutics (UTHR) in Q3 2020, closing a stake of 2,215 shares — an estimated $268K sold.

V Wealth Advisors first reported a position in UTHR in Q2 2020 and held it in 1 quarter. The position peaked at $268K in Q2 2020. 333 funds tracked by Wall St. Rank hold UTHR as of Q3 2020.

V Wealth Advisors reported no remaining United Therapeutics position as of Q3 2020 after selling out during the quarter.
V Wealth Advisors sold 2,215 United Therapeutics shares in Q3 2020, an estimated $268K.
V Wealth Advisors first reported a position in United Therapeutics in Q2 2020 and held it in 1 quarter.
V Wealth Advisors's United Therapeutics position peaked at $268K in Q2 2020.
333 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2020.

Based on V Wealth Advisors's 13F filing for Q3 2020, filed 13 Oct 2020.